newsfilter
← Latest News
PR Newswire·

MYND Diagnostics Commences Clinical Research on Alzheimer's Disease

The Company will be initiating a clinical validation study on the use of its proprietary biomarker testing in Alzheimer's Disease diagnostics VANCOUVER, BC, Nov. 16, 2021 /PRNewswire/ - MYND LIFE SCIENCES INC. ("MYND" or the "Company") (CSE